Results 171 to 180 of about 1,641 (192)
Some of the next articles are maybe not open access.
Activity of delafloxacin versus that of levofloxacin against anaerobic and microaerophilic isolates
Anaerobe, 2020The aim of the study was to comparatively assess delafloxacin and levofloxacin activities against 96 anaerobic and some microaerophilic isolates. Delafloxacin minimal inhibitory concentrations (MICs) were strikingly lower than those of levofloxacin. Delafloxacin MIC90 against clostridia, other Gram-positive rods, anaerobic/microaerophilic cocci and ...
Lyudmila Boyanova +5 more
openaire +2 more sources
Pharmacokinetics of Intravenous Delafloxacin in Patients With End‐Stage Renal Disease
The Journal of Clinical Pharmacology, 2018AbstractThis was an open‐label, parallel‐group, crossover study that examined the pharmacokinetics and safety of delafloxacin, an anionic fluoroquinolone, after a single intravenous infusion in subjects with end‐stage renal disease (ESRD; creatinine clearance <15 mL/min) undergoing hemodialysis compared with healthy subjects.
Randall Hoover +5 more
openaire +2 more sources
Orthopaedic Proceedings
Aim S. epidermidis SE and S. haemolyticus SH are commensal bacteria from skin microbiota. Both species are involved in device-related infections, especially hip, knee or shoulder bone and joint infections.
Ruffier d'Epenoux Louise +5 more
openaire +1 more source
Aim S. epidermidis SE and S. haemolyticus SH are commensal bacteria from skin microbiota. Both species are involved in device-related infections, especially hip, knee or shoulder bone and joint infections.
Ruffier d'Epenoux Louise +5 more
openaire +1 more source
Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole
Journal of the American Pharmacists Association, 2018Daniel A, Hussar, Molly A, Walter
openaire +2 more sources